Anthem Biosciences IPO allotment status online check can be done through the websites of BSE and NSE, along with the official ...

Landmark preclinical data validate Renovaro's platform representing a step forward in the fight against pancreatic and solid tumors LOS ANGELES, CALIFORNIA / ACCESS Newswire / July 17, 2025 / Renovaro ...

Harvard Bioscience (HBIO) announced a CEO succession plan under which John Duke will assume the role of president & CEO following the planned retirement of Jim Green, effective July 28, 2025.

The initial public offer of Anthem Biosciences received bids for 2,81,45,24,128 shares as against 4,40,70,682 shares on offer. The issue was subscribed 63.86 times.

International Flavors & Fragrances Inc. (NYSE:IFF) is one of the best chemical stocks to buy, according to billionaires.

Windtree Therapeutics, a Nasdaq listed biotechnology company, has plans to raise up to $200 million to build a treasury of ...

At the facility developed in partnership with the distillery, Meridian Biotech will convert Buffalo Trace's by-products ...

Niagen Bioscience CEO Robert Fried discusses the science of NAD, the problems with the supplement industry, and how his company is leading the way in anti-aging research.

The company will also add a warning label to its drug Elevidys after the deaths of two teenage patients this year.

Famous for the "de-extinction" of certain animals, Colossal Biosciences tackles the Jurassic World comparisons head-on.

Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...

Some of the most high-profile acquisitions in recent years have involved women-fronted biotechs. BioSpace reviews five of the ...